{"ticker": {"uuid": "60bd5e16-5f60-4d8f-9c5a-1c0cc78f16eb", "symbol": "001630", "name": "Chong Kun Dang Holdings Corp.", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Price to sales forward of Chong Kun Dang Holdings Co., Ltd. \u2013 KRX:001630", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNTWRPdGs3bExYRmVwZHhRbkVYdFR2alZUZmpFak9nU2dVU3R5Skt6eHpIN29SU1pMNUp5ZWhCWFNocng5Sm5aUDJROFBXRHc0c0NocThwRnRUSkxkYlBZUVExeHZvZGdTTDllLWNtbTJkclZKaldXeV9OZ05lblBfRUpKaFBJblJENlJOTFR3U2tjLUo2ZG5iMVNRNVo?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T08:37:37+00:00", "published_display": "04 Jul 2026 08:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang Launches Archela for Drug Development", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNMVFCcVEwUmNXUndUZXdMcU9PdGZDLVhJVEUzZUlncjlTT0ZFNDJya1Y3andocFEtSjJIaEtUSDNGUVAzSVFnNVk0OGRnQnJBNWwzcW9MTW92S1h5RUN0MnNzbWJUdm90Rk1pV1pDdExOT1MxZ0h0ZGczM3JpcVdiMzBKMVlTbjFM?oc=5", "source_name": "\uc870\uc120\uc77c\ubcf4", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang invests \u20a912.2 bil in AbClon, gains CAR-T commercialization rights", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZM1ViT1hFdEg4UWNCNU9MTzdydFNXcUlOalljcDd0YkRwRWFVZ2FGdVFDM09zckNEVWZHbWxrQzN3TTBPdGM5Z2NiblpmQTNPT0tFQmhPaXRlSUc2MU1DN3ZKQ2I2T0JVY3dCR0lB0gFyQVVfeXFMTnhMRUlBMDcwb0tnV0wtaHV1c0RYVEdMSWE1OEd2SW1uMWJCa3kwRVYtQTZNMUU1blhkMlJmM2FmR1Q2d2t5VFBMS0ZhQk5yVW5aeWF1T2FiS0lHZExiMENqNUFjSFZVZk1reWw5cDVrU2tR?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-05-12T07:00:00+00:00", "published_display": "12 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang launches dual-format product to capture bigger share of South Korea\u2019s thriving hangover cure market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPQnVuRkU5a2YwOVVEdzdQVHJUTFJ1OVhSYVVWSUJLLXpLM2pYNEVEQ1ltZDRqaUxySTVHaEFsTHhwMnBnaDUwcmN4R0ZCaXd1cFpOaTRXaEZONHM1MjFqMUZpaUNXampHX0Q1dDJsNk5TUzlnakRjSGo2RTdrc21Yd0xKRGMyR1EwblhzVVA4dHdwSG5ncjl4Zkwxa281UE9mZXpQWGxuRWMwcFM1YzcwUnBya0xRb29QLVBCTzV1WTQ1c3JXenMxNDg4Vng1WmRnS3c?oc=5", "source_name": "NutraIngredients.com", "published_at": "2024-10-09T07:00:00+00:00", "published_display": "09 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brand new: Chong Kun Dang Healthcare rides on GLP-1 boom and new launches from Fast&Up, Kalbe", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNcmV0Tmo0VnBNeWFCb2dCQkU4RWJ5bFJZc0NzVDAyLWNBZDNZek9oRVpxMDREUVNfSjIwVktQcjZmWDNHMkpId184UXExaGF6OXZMTzJOdUlOTW9JUTM3bHZnUVp4VjRpRUJkNXk2Vnh4Q2xKWGMxLW9mS0xEcVZFM08wV3dGWG5CSTl0RzQ4TUZZNlNOeEQzNzRYMTBYeXJOZ2lBX0pkS05VR3p4XzFyXzcxU3hxZkllVDBCVVNFWWpicUVo?oc=5", "source_name": "NutraIngredients.com", "published_at": "2024-06-28T07:00:00+00:00", "published_display": "28 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang scores its \u2018largest ever\u2019 $1.3B deal with Novartis for CKD-510", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOeml2N1hOSU5FZEl1dGs3M3Q3Um42RXN4ZHZ4ZUxsVzBZXzRQYk96cENISFlObmJ1VkRLZlQ3YVZoQzFjNEdYekNDRExwWm1QX05KX250cElmWmR1Y1JGVUlKRW55OHlfNEF4eHc2dnBDc3p2TElrQXcwWWhXSGRVOWs4ZzVYVWVPSkJnMDdfc2Z5enFOQ3ZmMmx4N0tqS1RSSDdzLTg3VEJDcXRmSDAxbHY3X20?oc=5", "source_name": "BioWorld News", "published_at": "2023-11-07T08:00:00+00:00", "published_display": "07 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang rallies on $1.3 bn deal with Novartis", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBhcUlYeWtzSjBPWkZ0OW1VbEx2M2xENGtTUWhhTnhBUGVqbUJiYVNsN0tNUFYyTDFNR0xMUjIyeE5CaEhKczZ2R0dIaGRMdWEzZjJDX0tlZUdKYUxlR2NfNDZGbzZwNTRkWmkyZHRR?oc=5", "source_name": "KED Global", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis Bags Chong Kun Dang\u2019s HDAC6 Inhibitor In $1.3bn Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxORHY0Yk1WSWRLZXJEOHJsSnJEQWMxM19ZTlVuNk9scFZWd3J3bGFTLTFxaGlIYXgydF9EdjU5XzZtSzVZa0JTaVVXZVZtblc0NkdMdk8yN1FfX1hRMG9rYmVDNnlrS3dIRGJWcXpfcUxPR1lRZzh4OFppaElMdTY0ejFPZXJtUkRiLWdWNmZzRGFYaFhQaXJ5VU1DS0p3aUE?oc=5", "source_name": "insights.citeline.com", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang licenses out HDAC6 inhibitor CKD-510 to Novartis for $1.3 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9uWmhVYmRXcXVFYjhrdDNqX010NzBmSGtKcll2Z09tMVhHdFdPUUVBNWZkU3NMUGxhYkthYlR1elBJcFNlM3J5bGR1VnBLdGFaUjQySGtlM0phNzAzV1k5VHl0Q0daUjVYOW1feUZR0gFyQVVfeXFMTnJBc0ROdkRyTUNRcXdNcWdiaGZXTW5QMDNTVlpKcl9DUWlwajJfU1FROFRpdEpOc3FhbXJVZTRIRUFvUmNFZ2NaTENLV3FmTzVzeXI1Zmtfbkk5TWJXVmdMWVV6OFF3U1praGktUWx6cDRn?oc=5", "source_name": "koreabiomed.com", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of Chong Kun Dang Holdings Co., Ltd. \u2013 KRX:001630", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNTWRPdGs3bExYRmVwZHhRbkVYdFR2alZUZmpFak9nU2dVU3R5Skt6eHpIN29SU1pMNUp5ZWhCWFNocng5Sm5aUDJROFBXRHc0c0NocThwRnRUSkxkYlBZUVExeHZvZGdTTDllLWNtbTJkclZKaldXeV9OZ05lblBfRUpKaFBJblJENlJOTFR3U2tjLUo2ZG5iMVNRNVo?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T08:37:37+00:00", "published_display": "04 Jul 2026 08:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang Launches Archela for Drug Development", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNMVFCcVEwUmNXUndUZXdMcU9PdGZDLVhJVEUzZUlncjlTT0ZFNDJya1Y3andocFEtSjJIaEtUSDNGUVAzSVFnNVk0OGRnQnJBNWwzcW9MTW92S1h5RUN0MnNzbWJUdm90Rk1pV1pDdExOT1MxZ0h0ZGczM3JpcVdiMzBKMVlTbjFM?oc=5", "source_name": "\uc870\uc120\uc77c\ubcf4", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang invests \u20a912.2 bil in AbClon, gains CAR-T commercialization rights", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZM1ViT1hFdEg4UWNCNU9MTzdydFNXcUlOalljcDd0YkRwRWFVZ2FGdVFDM09zckNEVWZHbWxrQzN3TTBPdGM5Z2NiblpmQTNPT0tFQmhPaXRlSUc2MU1DN3ZKQ2I2T0JVY3dCR0lB0gFyQVVfeXFMTnhMRUlBMDcwb0tnV0wtaHV1c0RYVEdMSWE1OEd2SW1uMWJCa3kwRVYtQTZNMUU1blhkMlJmM2FmR1Q2d2t5VFBMS0ZhQk5yVW5aeWF1T2FiS0lHZExiMENqNUFjSFZVZk1reWw5cDVrU2tR?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-05-12T07:00:00+00:00", "published_display": "12 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang launches dual-format product to capture bigger share of South Korea\u2019s thriving hangover cure market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPQnVuRkU5a2YwOVVEdzdQVHJUTFJ1OVhSYVVWSUJLLXpLM2pYNEVEQ1ltZDRqaUxySTVHaEFsTHhwMnBnaDUwcmN4R0ZCaXd1cFpOaTRXaEZONHM1MjFqMUZpaUNXampHX0Q1dDJsNk5TUzlnakRjSGo2RTdrc21Yd0xKRGMyR1EwblhzVVA4dHdwSG5ncjl4Zkwxa281UE9mZXpQWGxuRWMwcFM1YzcwUnBya0xRb29QLVBCTzV1WTQ1c3JXenMxNDg4Vng1WmRnS3c?oc=5", "source_name": "NutraIngredients.com", "published_at": "2024-10-09T07:00:00+00:00", "published_display": "09 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brand new: Chong Kun Dang Healthcare rides on GLP-1 boom and new launches from Fast&Up, Kalbe", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNcmV0Tmo0VnBNeWFCb2dCQkU4RWJ5bFJZc0NzVDAyLWNBZDNZek9oRVpxMDREUVNfSjIwVktQcjZmWDNHMkpId184UXExaGF6OXZMTzJOdUlOTW9JUTM3bHZnUVp4VjRpRUJkNXk2Vnh4Q2xKWGMxLW9mS0xEcVZFM08wV3dGWG5CSTl0RzQ4TUZZNlNOeEQzNzRYMTBYeXJOZ2lBX0pkS05VR3p4XzFyXzcxU3hxZkllVDBCVVNFWWpicUVo?oc=5", "source_name": "NutraIngredients.com", "published_at": "2024-06-28T07:00:00+00:00", "published_display": "28 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang scores its \u2018largest ever\u2019 $1.3B deal with Novartis for CKD-510", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOeml2N1hOSU5FZEl1dGs3M3Q3Um42RXN4ZHZ4ZUxsVzBZXzRQYk96cENISFlObmJ1VkRLZlQ3YVZoQzFjNEdYekNDRExwWm1QX05KX250cElmWmR1Y1JGVUlKRW55OHlfNEF4eHc2dnBDc3p2TElrQXcwWWhXSGRVOWs4ZzVYVWVPSkJnMDdfc2Z5enFOQ3ZmMmx4N0tqS1RSSDdzLTg3VEJDcXRmSDAxbHY3X20?oc=5", "source_name": "BioWorld News", "published_at": "2023-11-07T08:00:00+00:00", "published_display": "07 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang rallies on $1.3 bn deal with Novartis", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBhcUlYeWtzSjBPWkZ0OW1VbEx2M2xENGtTUWhhTnhBUGVqbUJiYVNsN0tNUFYyTDFNR0xMUjIyeE5CaEhKczZ2R0dIaGRMdWEzZjJDX0tlZUdKYUxlR2NfNDZGbzZwNTRkWmkyZHRR?oc=5", "source_name": "KED Global", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis Bags Chong Kun Dang\u2019s HDAC6 Inhibitor In $1.3bn Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxORHY0Yk1WSWRLZXJEOHJsSnJEQWMxM19ZTlVuNk9scFZWd3J3bGFTLTFxaGlIYXgydF9EdjU5XzZtSzVZa0JTaVVXZVZtblc0NkdMdk8yN1FfX1hRMG9rYmVDNnlrS3dIRGJWcXpfcUxPR1lRZzh4OFppaElMdTY0ejFPZXJtUkRiLWdWNmZzRGFYaFhQaXJ5VU1DS0p3aUE?oc=5", "source_name": "insights.citeline.com", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chong Kun Dang licenses out HDAC6 inhibitor CKD-510 to Novartis for $1.3 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9uWmhVYmRXcXVFYjhrdDNqX010NzBmSGtKcll2Z09tMVhHdFdPUUVBNWZkU3NMUGxhYkthYlR1elBJcFNlM3J5bGR1VnBLdGFaUjQySGtlM0phNzAzV1k5VHl0Q0daUjVYOW1feUZR0gFyQVVfeXFMTnJBc0ROdkRyTUNRcXdNcWdiaGZXTW5QMDNTVlpKcl9DUWlwajJfU1FROFRpdEpOc3FhbXJVZTRIRUFvUmNFZ2NaTENLV3FmTzVzeXI1Zmtfbkk5TWJXVmdMWVV6OFF3U1praGktUWx6cDRn?oc=5", "source_name": "koreabiomed.com", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 55, "total_relevant": 9, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 8, "score": 52, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 39400.0, "latest_week": "2026-07-10", "one_week_move": -2.0, "four_week_move": -5.2, "twelve_week_move": -19.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.318006, "market_dynamics_buy_signal": false, "relative_strength": -47.872939, "fair_value_gap": -20.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.771, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.0% over one week, -5.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "koreabiomed.com", "count": 2}, {"label": "NutraIngredients.com", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "\uc870\uc120\uc77c\ubcf4", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "KED Global", "count": 1}, {"label": "insights.citeline.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Deals and strategy", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.0% over one week, -5.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of Chong Kun Dang Holdings Co., Ltd. \u2013 KRX:001630"}], "updated_at": "2026-07-17T23:11:26.976917+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}